Innate immune sensing and signaling of cytosolic nucleic acids

Annual Review of Immunology

Volumn 32, Issue , 2014, Pages 461-488

  Wu, Jiaxi ^a   Chen, Zhijian J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; CGAMP; CGAS; Cyclic GMP AMP; Cyclic GMP AMP synthase; DNA sensor; Interferons; IRF3; MAVS; MDA5; NF B; Pattern recognition receptor; RIG I; RNA sensor; STING

Indexed keywords

CYTOKINE; DNA; INTERFERON; NUCLEIC ACID; PATTERN RECOGNITION RECEPTOR; RNA; TOLL LIKE RECEPTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOKINE PRODUCTION; CYTOSOL; ENDOSOME; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; INTERFERON PRODUCTION; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SENSOR; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; CYTOSOL; ENDOSOMES; HUMANS; IMMUNITY, INNATE; NUCLEIC ACIDS; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84896958063     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-032713-120156     Document Type: Review

References (181)

1. Kawai T, Akira S. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637-50
2. Ablasser A, Hertrich C, Warmann R, Hornung V. 2013. Nucleic acid driven sterile inflammation. Clin. Immunol. 147:207-15
3. Platanias LC. 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5:375-86
4. Silverman N, Maniatis T. 2001. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15:2321-42
5. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, et al. 2003. IKK? and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-96
6. Sharma S, tenOever BR, Grandvaux N, Zhou G-P, Lin R, Hiscott J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-51
7. Honda K, Taniguchi T. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6:644-58
8. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Tolllike receptors. Nat. Immunol. 11:373-84
9. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732-38
10. Negishi H, Osawa T, Ogami K, Ouyang X, Sakagushi S, et al. 2008. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. USA 105:20446-51
11. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801
12. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529-31
13. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, et al. 2004. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303:1526-29
14. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, et al. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:196-200
15. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-45
16. Li X-D, Chen ZJ. 2012. Sequence specific detection of bacterial 23S ribosomal RNA by TLR13. eLife 1:300102
17. Oldenburg M, Kr ?uger A, Ferstl R, Kaufmann A, Nees G, et al. 2012. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 337:1111-15
18. Goubau D, Deddouche S, Reis e Sousa C. 2013. Cytosolic sensing of viruses. Immunity 38:855-69
19. Diebold SS, Montoya M, Unger H, Alexopoulou L, Roy P, et al. 2003. Viral infection switches nonplasmacytoid dendritic cells into high interferon producers. Nature 424:324-28
20. Yoneyama M, KikuchiM, Natsukawa T, Shinobu N, Imaizumi T, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-37
21. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, et al. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175:2851-58
22. Kolakofsky D, Kowalinski E, Cusack S. 2012. A structure-based model of RIG-I activation. RNA 18:2118-27
23. Luo D, Kohlway A, Pyle AM. 2013. DuplexRNAactivated ATPases (DRAs): platforms forRNAsensing, signaling and processing. RNA Biol. 10:111-20
24. Jiang X, Kinch LN, Brautigam CA, Chen X, Du F, et al. 2012. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 36:959-73
25. Yoneyama M, Fujita T. 2010. Recognition of viral nucleic acids in innate immunity. Rev. Med. Virol. 20:4-22
26. Venkataraman T, Valdes M, Elsby R, Kakuta S, Caceres G, et al. 2007. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 178:6444-55
27. Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, et al. 2010. LGP2 is a positive regulator of RIG-Iand MDA5-mediated antiviral responses. Proc. Natl. Acad. Sci. USA 107:1512-17
28. Gitlin L, BarchetW, Gilfillan S, Cella M, Beutler B, et al. 2006. Essential role of MDA5 in type I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA 103:8459-64
29. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-5
30. Fredericksen BL, Keller BC, Fornek J, KatzeMG, Gale M. 2008. Establishment and maintenance of the innate antiviral response to West Nile virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 82:609-16
31. Loo Y-M, Fornek J, CrochetN, Bajwa G, Perwitasari O, et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82:335-45
32. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, et al. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation- associated gene 5. J. Exp. Med. 205:1601-10
33. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al. 2006. 5-triphosphate RNA is the ligand for RIG-I. Science 314:994-97
34. Pichlmair A, Schulz O, Tan CP, Nslund TI, Liljestrm P, et al. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5-phosphates. Science 314:997-1001
35. Schlee M, Roth A, Hornung V, Hagmann CA,Wimmenauer V, et al. 2009. Recognition of 52 triphosphate byRIG-I helicase requires short blunt double-strandedRNAas contained in panhandle of negativestrand virus. Immunity 31:25-34
36. Schmidt A, Schwerd T, Hamm W, Hellmuth JC, Cui S, et al. 2009. 5-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc. Natl. Acad. Sci. USA 106:12067-72
37. Malathi K, Dong B, Gale M, Silverman RH. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448:816-19
38. Malathi K, Saito T, Crochet N, Barton DJ, Gale M Jr, Silverman RH. 2010. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 16:2108-19
39. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, et al. 2010. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140:397-408
40. Baum A, Sachidanandam R, Garc-Sastre A. 2010. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc. Natl. Acad. Sci. USA 107:16303-8
41. Feng Q, Hato SV, Langereis MA, Zoll J, Virgen-Slane R, et al. 2012. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep. 2:1187-96
42. Pichlmair A, Schulz O, Tan C-P, Rehwinkel J, Kato H, et al. 2009. Activation of MDA5 requires higherorder RNA structures generated during virus infection. J. Virol. 83:10761-69
43. Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, et al. 2011. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147:423-35
44. Leung DW, Amarasinghe GK. 2012. Structural insights into RNA recognition and activation of RIGI- like receptors. Curr. Opin. Struct. Biol. 22:297-303
45. Jiang F, Ramanathan A,MillerMT, Tang G-Q, Gale M, et al. 2011. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479:423-27
46. Luo D, Ding SC, Vela A, Kohlway A, Lindenbach BD, Pyle AM. 2011. Structural insights into RNA recognition by RIG-I. Cell 147:409-22
47. Civril F, Bennett M, MoldtM, Deimling T,Witte G, et al. 2011. The RIG-I ATPase domain structure reveals insights into ATP-dependent antiviral signalling. EMBO Rep. 12:1127-34
48. Gack MU, Shin YC, Joo C-H, Urano T, Liang C, et al. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-20
49. Oshiumi H, Matsumoto M, Hatakeyama S, Seya T. 2009. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-βinduction during the early phase of viral infection. J. Biol. Chem. 284:807-17
50. Oshiumi H, Miyashita M, Inoue N, Okabe M, Matsumoto M, Seya T. 2010. The ubiquitin ligase riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 8:496-509
51. Zeng W, Sun L, Jiang X, Chen X, Hou F, et al. 2010. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141:315-30
52. Peisley A, Lin C, Wu B, Orme-Johnson M, Liu M, et al. 2011. Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition. Proc. Natl. Acad. Sci. USA 108:21010-15
53. Berke IC, Yu X, Modis Y, Egelman EH. 2012. MDA5 assembles into a polar helical filament on dsRNA. Proc. Natl. Acad. Sci. USA 109:18437-41
54. Berke IC, Modis Y. 2012. MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA. EMBO J. 31:1714-26
55. Wu B, Peisley A, Richards C, Yao H, Zeng X, et al. 2013. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152:276-89
56. Seth RB, Sun L, Ea C-K, Chen ZJ. 2005. Identification and characterization ofMAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 122:669-82
57. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. 2005. IPS-1, an adaptor triggering RIG-Iand Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-88
58. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-72
59. Xu L-G, Wang Y-Y, Han K-J, Li L-Y, Zhai Z, Shu H-B. 2005. VISA is an adapter protein required for virus-triggered IFN-βsignaling. Mol. Cell 19:727-40
60. Sun Q, Sun L, Liu H-H, Chen X, Seth RB, et al. 2006. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24:633-42
61. Kumar H, Kawai T, Kato H, Sato S, Takahashi K, et al. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203:1795-803
62. Hou F, Sun L, Zheng H, Skaug B, Jiang Q-X, Chen ZJ. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146:448-61
63. Li X-D, Sun L, Seth RB, Pineda G, Chen ZJ. 2005. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA 102:17717-22
64. Castanier C, Garcin D, Vazquez A, Arnoult D. 2010. Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway. EMBO Rep. 11:133-38
65. Onoguchi K, OnomotoK,Takamatsu S, Jogi M, Takemura A, et al. 2010. Virus-infection or 5-ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog. 6:e1001012
66. Yasukawa K, Oshiumi H, Takeda M, IshiharaN, Yanagi Y, et al. 2009. Mitofusin 2 inhibits mitochondrial antiviral signaling. Sci. Signal. 2:ra47
67. Koshiba T, Yasukawa K, Yanagi Y, Kawabata S-i. 2011. Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. Sci. Signal. 4:ra7
68. Ea C-K, Deng L, Xia Z-P, Pineda G, Chen ZJ. 2006. Activation of IKK by TNFαrequires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22:245-57
69. WuC-J, ConzeDB, Li T, Srinivasula SM, Ashwell JD. 2006. Sensing ofLys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation. Nat. Cell Biol. 8:398-406
70. Zeng W, Xu M, Liu S, Sun L, Chen ZJ. 2009. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol. Cell 36:315-25
71. Paz S, Vilasco M, Werden SJ, Arguello M, Joseph-Pillai D, et al. 2011. A functional C-terminal TRAF3- binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res. 21:895-910
72. Saha SK, Pietras EM, He JQ, Kang JR, Liu S-Y, et al. 2006. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25:3257-63
73. Tang ED,WangCY. 2010.TRAF5is a downstream target ofMAVSin antiviral innate immune signaling. PLoS ONE 5:e9172
74. Li S, Wang L, Berman M, Kong Y-Y, Dorf ME. 2011. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 35:426-40
75. Mao A-P, Li S, Zhong B, Li Y, Yan J, et al. 2010. Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-β(IFN-β) and cellular antiviral response. J. Biol. Chem. 285:9470-76
76. Liu S, Chen J, Cai X, Wu J, Chen X, et al. 2013. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. eLife 2:e00785
77. Oshiumi H, MatsumotoM, Seya T. 2012. Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I. J. Biochem. 151:5-11
78. Arimoto K-i, Takahashi H, Hishiki T, Konishi H, Fujita T, Shimotohno K. 2007. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc. Natl. Acad. Sci. USA 104:7500-5
79. Chen W, Han C, Xie B, Hu X, Yu Q, et al. 2013. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell 152:467-78
80. Friedman CS, O'Donnell MA, Legarda-Addison D, Ng A, Cardenas WB, et al. 2008. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 9:930-36
81. Wang L, Zhao W, Zhang M,Wang P, Zhao K, et al. 2013. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. J. Virol. 87:4507-15
82. Gack MU, Nistal-Villn E, Inn K-S, Garc-Sastre A, Jung JU. 2010. Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J. Virol. 84:3220-29
83. Nistal-Villn E, Gack MU, Martez-Delgado G, Maharaj NP, Inn K-S, et al. 2010. Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-βproduction. J. Biol. Chem. 285:20252-61
84. Wies E, Wang MK, Maharaj NP, Chen K, Zhou S, et al. 2013. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 38:437-49
85. Kim M-J, Hwang S-Y, Imaizumi T, Yoo J-Y. 2008. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J. Virol. 82:1474-83
86. Mi Z, Fu J, Xiong Y, Tang H. 2010. SUMOylation of RIG-I positively regulates the type I interferon signaling. Protein Cell 1:275-83
87. Bozym RA, Delorme-Axford E, Harris K, Morosky S, Ikizler M, et al. 2012. Focal adhesion kinase is a component of antiviral RIG-I-like receptor signaling. Cell Host Microbe 11:153-66
88. Hayakawa S, Shiratori S, Yamato H, Kameyama T, Kitatsuji C, et al. 2011. ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat. Immunol. 12:37-44
89. Kok K-H, Lui P-Y, Ng MHJ, Siu K-L, Au SWN, Jin D-Y. 2011. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 9:299-309
90. Chen H, Li Y, Zhang J, Ran Y, Wei J, et al. 2013. RAVER1 is a coactivator of MDA5-mediated cellular antiviral response. J. Mol. Cell Biol. 5:111-19
91. Liu HM, Loo Y-M, Horner SM, Zornetzer GA, Katze MG, Gale M Jr. 2012. The mitochondrial targeting chaperone 14-3-3 regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe 11:528-37
92. Wang Y, Tong X, Li G, Li J, Deng M, Ye X. 2012. Ankrd17 positively regulates RIG-I-like receptor (RLR)-mediated immune signaling. Eur. J. Immunol. 42:1304-15
93. Xu L, Xiao N, Liu F, Ren H, Gu J. 2009. Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria. Proc. Natl. Acad. Sci. USA 106:1530-35
94. RobertsWK, Hovanessian ARA, Brown RE, Clemens MJ, Kerr IM. 1976. Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis. Nature 264:477-80
95. MinksMA, West DK, Benvin S, Baglioni C. 1979. Structural requirements of double-stranded RNA for the activation of 2-,5-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J. Biol. Chem. 254:10180-83
96. Silverman RH. 2007. Viral encounters with 2-,5-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 81:12720-29
97. Williams BRG. 2001. Signal integration via PKR. Sci. STKE 2001:re2
98. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, et al. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129-41
99. Yang YL, Reis LF, Pavlovic J, Aguzzi A, Schafer R, et al. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:6095-106
100. Stetson DB, Medzhitov R. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24:93-103
101. Ishii KJ, Coban C, KatoH, Takahashi K, Torii Y, et al. 2006. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7:40-48
102. Cheng G, Zhong J, Chung J, Chisari FV. 2007. Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc. Natl. Acad. Sci. USA 104:9035-40
103. Choi MK, Wang Z, Ban T, Yanai H, Lu Y, et al. 2009. A selective contribution of the RIG-I-like receptor pathway to type I interferon responses activated by cytosolic DNA. Proc. Natl. Acad. Sci. USA 106(42):17870-75
104. Chiu Y-H, MacMillan JB, Chen ZJ. 2009. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138:576-91
105. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. 2009. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10:1065-72
106. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-78
107. Zhong B, Yang Y, Li S, Wang Y-Y, Li Y, et al. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29:538-50
108. Sun W, Li Y, Chen L, Chen H, You F, et al. 2009. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl. Acad. Sci. USA 106:8653-58
109. Ouyang S, Song X, Wang Y, Ru H, ShawN, et al. 2012. Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding. Immunity 36:1073-86
110. Yin Q, Tian Y, Kabaleeswaran V, Jiang X, Tu D, et al. 2012. Cyclic di-GMP sensing via the innate immune signaling protein STING. Mol. Cell 46:735-45
111. Ishikawa H,Ma Z, Barber GN. 2009. STING regulates intracellular DNA-mediated, type I interferondependent innate immunity. Nature 461:788-92
112. Sauer J-D, Sotelo-TrohaK, von Moltke J, Monroe KM,Rae CS, et al. 2011. TheN-ethyl-N-nitrosoureainduced Goldenticket mousemutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect. Immun. 79:688-94
113. Saitoh T, Fujita N, Hayashi T, Takahara K, Satoh T, et al. 2009. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc. Natl. Acad. Sci. USA 106:20842-46
114. Tanaka Y, Chen ZJ. 2012. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal. 5:ra20
115. Burdette DL, Vance RE. 2013. STING and the innate immune response to nucleic acids in the cytosol. Nat. Immunol. 14:19-26
116. Chen H, Sun H, You F, Sun W, Zhou X, et al. 2011. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 147:436-46
117. Tamayo R, Pratt JT, Camilli A. 2007. Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. Annu. Rev. Microbiol. 61:131-48
118. Romling U. 2008. Great times for small molecules: c-di-AMP, a second messenger candidate in Bacteria and Archaea. Sci. Signal. 1:pe39
119. Davies BW, Bogard RW, Young TS, Mekalanos JJ. 2012. Coordinated regulation of accessory genetic elements produces cyclic di-nucleotides for V. cholerae virulence. Cell 149:358-70
120. McWhirter SM, Barbalat R, Monroe KM, Fontana MF, Hyodo M, et al. 2009. A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP. J. Exp. Med. 206:1899-911
121. Woodward JJ, Iavarone AT, Portnoy DA. 2010. c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science 328:1703-5
122. Jin L, Hill KK, Filak H, Mogan J, Knowles H, et al. 2011. MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP. J. Immunol. 187:2595-601
123. Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, et al. 2011. STING is a direct innate immune sensor of cyclic di-GMP. Nature 478:515-18
124. Huang Y-H, LiuX-Y,DuX-X, Jiang Z-F, SuX-D. 2012. The structural basis for the sensing and binding of cyclic di-GMP by STING. Nat. Struct. Mol. Biol. 19:728-30
125. Shang G, Zhu D, Li N, Zhang J, Zhu C, et al. 2012. Crystal structures of STING protein reveal basis for recognition of cyclic di-GMP. Nat. Struct. Mol. Biol. 19:725-27
126. Shu C, Yi G, Watts T, Kao CC, Li P. 2012. Structure of STING bound to cyclic di-GMP reveals the mechanism of cyclic dinucleotide recognition by the immune system. Nat. Struct. Mol. Biol. 19:722-24
127. Zhang X, Shi H,WuJ, Zhang X, Sun L, et al. 2013. Cyclic GMP-AMP containingmixed phosphodiester linkages is an endogenous high-Affinity ligand for STING. Mol. Cell 51:226-35
128. Sun L,Wu J, Du F, Chen X, Chen ZJ. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-91
129. Wu J, Sun L, Chen X, Du F, Shi H, et al. 2013. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339:826-30
130. Xiao TS, Fitzgerald KA. 2013. The cGAS-STING Pathway for DNA sensing. Mol. Cell 51:135-39
131. Gao D, Wu J, Wu Y-T, Du F, Aroh C, et al. 2013. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341:903-6
132. Li X-D, Wu J, Gao D, Wang H, Sun L, Chen ZJ. 2013. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341:1390-94
133. Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, et al. 2014. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature. In press. doi: 10.1038/ nature12862
134. Lahaye X, Satoh T, Gentili M, Cerboni S, Conrad C, et al. 2013. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 39:1132-42
135. Rasaiyaah J, Tan CP, Fletcher AJ, Price AJ, Blondeau C, et al. 2013. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503:402-5
136. Gao P, AscanoM,Wu Y, Barchet W, Gaffney BL, et al. 2013. Cyclic [G(2-,5-)pA(3-,5-)p] is the metazoan second messenger produced by DNA-Activated cyclic GMP-AMP synthase. Cell 153:1094-107
137. Kranzusch PJ, Lee AS-Y, Berger JM, Doudna JA. 2013. Structure of human cGAS reveals a conserved family of second-messenger enzymes in innate immunity. Cell Rep. 3:1362-68
138. Civril F, Deimling T, de Oliveira Mann CC, Ablasser A,Moldt M, et al. 2013. Structural mechanism of cytosolic DNA sensing by cGAS. Nature 498:332-37
139. Diner EJ, Burdette DL, Wilson SC, Monroe KM, Kellenberger CA, et al. 2013. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep. 3:1355-61
140. Ablasser A,Goldeck M, Cavlar T, Deimling T,Witte G, et al. 2013. cGAS produces a 2-5-linked cyclic dinucleotide second messenger that activates STING. Nature 498:380-84
141. Ablasser A, Schmid-Burgk JL, Hemmerling I, Horvath GL, Schmidt T, et al. 2013. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 503:530-34
142. Konno H, Konno K, Barber GN. 2013. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell 155:688-98
143. EganDF, Shackelford DB,Mihaylova MM, Gelino S, Kohnz RA, et al. 2011. Phosphorylation ofULK1 (hATG1) by AMP-Activated protein kinase connects energy sensing to mitophagy. Science 331:456-61
144. Alers S, Loffler AS, Wesselborg S, Stork B. 2012. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol. Cell. Biol. 32(1):2-11
145. Gao P, Ascano M, Zillinger T, Wang W, Dai P, et al. 2013. Structure-function analysis of STING activation by c[G(2-,5-)pA(3-,5-)p] and targeting by antiviral DMXAA. Cell 154:748-62
146. Paludan SR, Bowie AG. 2013. Immune sensing of DNA. Immunity 38:870-80
147. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, et al. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501-5
148. Ishii KJ, Kawagoe T, Koyama S, Matsui K, Kumar H, et al. 2008. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451:725-29
149. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, et al. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11:997-1004
150. OrzalliMH,DeLucaNA, KnipeDM. 2012. Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc. Natl. Acad. Sci. USA 109:E3008-17
151. Kerur N, VeettilMohanan V, Sharma-Walia N, Bottero V, Sadagopan S, et al. 2011. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-Associated herpesvirus infection. Cell Host Microbe 9:363-75
152. Brunette RL, Young JM, Whitley DG, Brodsky IE,Malik HS, StetsonDB. 2012. Extensive evolutionary and functional diversity among mammalian AIM2-like receptors. J. Exp. Med. 209:1969-83
153. Abe T, Harashima A, Xia T, Konno H, Konno K, et al. 2013. STING recognition of cytoplasmic DNA instigates cellular defense. Mol. Cell 50:5-15
154. Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu Y-J. 2011. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12:959-65
155. Parvatiyar K, Zhang Z, Teles RM, Ouyang S, Jiang Y, et al. 2012. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat. Immunol. 13:1155-61
156. Zhang Z, Bao M, Lu N, Weng L, Yuan B, Liu Y-J. 2013. The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA. Nat. Immunol. 14:172-78
157. LamE, Stein S, Falck-PedersenE. 2014. Adenovirus detection by the GAS/STING/TBK1DNAsensing cascade. J. Virol. 88:974-81
158. Stein SC, Lam E, Falck-Pedersen E. 2012. Cell-specific regulation of nucleic acid sensor cascades: a controlling interest in the antiviral response. J. Virol. 86:13303-12
159. Ferguson BJ, Mansur DS, Peters NE, Ren H, Smith GL. 2012. DNA-PK is a DNA sensor for IRF- 3-dependent innate immunity. eLife 1:e00047
160. Zhang X, Brann TW, Zhou M, Yang J, Oguariri RM, et al. 2011. Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J. Immunol. 186:4541-5
161. Kondo T, Kobayashi J, Saitoh T, Maruyama K, Ishii KJ, et al. 2013. DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc. Natl. Acad. Sci. USA 110:2969-74
162. Muruve DA, Petrilli V, Zaiss AK, White LR, Clark SA, et al. 2008. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452:103-7
163. Fernandes-Alnemri T, Yu J-W, Datta P, Wu J, Alnemri ES. 2009. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458:509-13
164. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, et al. 2009. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-Activating inflammasome with ASC. Nature 458:514-18
165. Burckstummer T, Baumann C, Bluml S, Dixit E, Durnberger G, et al. 2009. An orthogonal proteomicgenomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 10:266-72
166. Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, et al. 2009. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323:1057-60
167. Fernandes-Alnemri T, Yu J-W, Juliana C, Solorzano L, Kang S, et al. 2010. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 11:385-93
168. Rathinam VAK, Jiang Z, Waggoner SN, Sharma S, Cole LE, et al. 2010. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11:395-402
169. Jones JW, Kayagaki N, Broz P, Henry T, Newton K, et al. 2010. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc. Natl. Acad. Sci. USA 107:9771-76
170. Crow YJ, Hayward BE, Parmar R, Robins P, Leitch A, et al. 2006. Mutations in the gene encoding the 3-5- DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat. Genet. 38:917-20
171. Morita M, Stamp G, Robins P, Dulic A, Rosewell I, et al. 2004. Gene-targeted mice lacking the Trex1 (DNase III) 3-5- DNA exonuclease develop inflammatory myocarditis. Mol. Cell. Biol. 24:6719-27
172. Stetson DB, Ko JS, Heidmann T,Medzhitov R. 2008. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134:587-98
173. Yang Y-G, Lindahl T, Barnes DE. 2007. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131:873-86
174. Gall A, Treuting P, Elkon KB, Loo Y-M, Gale M Jr, et al. 2012. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36:120-31
175. Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J. 2010. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 11:1005-13
176. Yoshida H, Okabe Y, Kawane K, Fukuyama H, Nagata S. 2005. Lethal anemia caused by interferon-β produced in mouse embryos carrying undigested DNA. Nat. Immunol. 6:49-56
177. Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, et al. 2006. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443:998-1002
178. Okabe Y, Kawane K, Akira S, Taniguchi T, Nagata S. 2005. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202:1333-39
179. Ahn J, Gutman D, Saijo S, Barber GN. 2012. STING manifests self DNA-dependent inflammatory disease. Proc. Natl. Acad. Sci. USA 109:19386-91
180. Li X, Shu C, Yi G, Chaton CT, Shelton CL, et al. 2013. Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization. Immunity 39(6):1019-31
181. Zhang X,Wu J, Du F, Xu H, Sun L, et al. 2014. The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch-like conformational changes in the activation loop. Cell Rep. In press. http://dx.doi.org/10.1016/j.celrep.2014.01.003